Our Team

HYPMED project result presentation in Münster (Germany), June 2022:
From 09.06. to 11.06.2022, the annual meeting of the German Society of Pathology took place in Münster. As part of the AG Dahl working group, Lehr- und Forschungsgebiet Tumorpathologie, Ms Cosima Kunze, medical doctoral student, presented her project in an invited lecture entitled "Class II tumour suppressor genes in breast cancer can be classified according to intrinsic molecular subtypes and may be suitable for risk classification of ductal carcinoma in situ (DCIS)". In front of a large audience, Ms Kunze explained our hypothesis that class II tumour suppressor genes (C2TSGs) in breast cancer may be suitable for risk classification of early stages (ductal carcinoma in situ). These findings are a result of work package 4 in the EU-HYPMED project (http://www.hypmed.eu), which was worked on jointly by Prof. Wardelmann (Münster) and Prof. Dahl (Aachen). The team is pleased with the successful lecture of Ms. Kunze and hopes for future progress in risk classification of DCIS using this approach.